The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Https://neurosciencenews.com/uk-alzheimers-blood-test-25867/
The new Tau test is from Alzpath (https://alzpath.bio/about/)
Shows university of Gothenburg is a partner in the evaluation.
Is the new p-tau217 test using Bioventix antibodies. Even if not, it is good news for Bioventix p-tau217 new assay for Alzheimer's.
https://www.bbc.co.uk/news/health-68726703
@hardboy? Why do you like that?
They are just earning 3.3percent on cash... Absolutely nothing impressive here. If anything they probably could get a better rate.
I like the fact that interest accounts for nearly 1.5% of their income. And has increased by 162%.
Can see nothing but very positive news in these results.
It was tipped in the Times in Nov. Results look good. Lots of pipeline to look at one. It only takes one of two of these to work. If Tau is the one then for me that is massive.
Anyone know what the succession planning is in place. Peter Harrison is 66
Also what really stops the like of siemens developing their own antiboidies rather than paying the royality
I know what you mean, I like to have a reason for an 'up' moment. I suppose the logic is that without a reason, there is no reason why it won't also retrace!
But, she's closed at £50 today for the first time. Got to be cause for a celebration?!
Yes the share price had flat lined for months then in November it began creeping up - no news that I've seen, and volumes are as low as ever,
Hope there is good news behind the rise.
Must be something brewing over at BVXP....
No complaints, but does anyone know if there is a reason for it.
BVXP ATH
Peter Harrison sold 62,000 shares today to enable a new institutional investor to get on board.
And back down again
There was a “buy” recommendation in the Times business pages a couple of weeks ago..
Search me. Wouldn’t be the first time that someone knows something that we don’t. If a positive RNS comes out in a few days it will be a proper eye rolling moment!
Does anyone know why the recent surge in share price? Volumes not increased noticeably
If you top-up now at our shorted depressed price you'll be locking in a nice yield of c.4%.
One further point the 2023 dividends of 152p looks to be no change on 2022. However, the 152p paid in 2022 included one of BVXP's regular special dividends of 26p. So, excluding this the dividends increased a very healthy 20.6%!
In the last five years BVXP has paid three Special Dividends - so that 4% is probably understated albeit the corp tax increase will slow cash accumulation.
If you're wondering about the price drop - we've picked up a shorter: Michael Taylor (shiftingshares). Very odd choice - yes BVXP is priced highly - but for very good reasons. So, courtesy of Michael you may wish to pick up some more at a good price.
That in the knowledge that at some point he's going to have to close his short ;-)
The Buffettology Fund (SANFORD DELAND ASSET MANAGEMENT LTD ) monthly news letter mentioned BVXP specifically and after outlining why they are so positive on BVXP they said they had never seen the CEO looking so happy as he did at their last meeting.
SANFORD DELAND ASSET MANAGEMENT LTD increase their stake of Bioventix in their ‘Buffetology’ fund. Talk about confidence in a stock.
Join us at the ShareSoc Growth Company #Seminar in London on 26/04/23. Register here: https://www.sharesoc.org/events/sharesoc-growth-company-live-seminar-london26-april-2023-5pm/
Companies presenting: Bioventix plc, Supermarket Income REIT and Challenger Energy Group PLC.
This seminar consists of a 25-minute presentation by each company followed by 15 minutes of questions and answers. Companies presenting are interesting growth companies of small/medium cap size. Attendees will have the opportunity to talk directly to the directors of the presenting companies. This is also a great opportunity to socialise with your fellow investors and discuss these and other investment opportunities.
Sorry everyone, wrong site, meant for Team 17. A share to invest in, just like Bioventix. Rare gems on the Aim list.